Headshot of Alisha Holloway

Dr. Alisha Holloway
CSO
Phylos Bioscience
PANELIST
GENOMICS WORKSHOP
POSTER PRESENTER
CULTIVATION

Bringing Advanced Breeding Technologies to Cannabis
Cannabis breeding is entering a new era, driven by technologies that are revolutionizing how we develop varieties. F1 hybrid seeds are the future of cannabis genetics, offering unrivaled vigor and yield, as well as consistent cannabinoid content and aroma. Seed-grown cannabis can increase available footprint, decrease cost of production, and IPM cost.

To develop seed-grown cannabis, we can implement the tools developed for other crops, including genetic marker-assisted selection as well as development of triploid lines and doubled haploids. In this presentation we will delve into groundbreaking discoveries and transformative strategies that are shaping the future of cannabis genetics, including a comparison of CRISPR gene editing and marker-assisted trait introgression. Attendees will learn how Phylos uses advanced modern breeding and data analytics to bring F1 hybrid seeds to market. Specifically, we will present research that led to the identification of genetic markers for stress tolerance. Through nested association mapping we identified genetic markers located on the X chromosome that are associated with hermaphroditism. We found genes near these markers that are responsible for this undesirable trait and are able to select against hermaphroditic plants in our breeding program, thus improving the ability of cultivators to grow valuable plants from seed.
BIO
Alisha Holloway is the Chief Scientific Officer at Phylos where she leads the R&D group that focuses on foundational genomic research, development of high-throughput genetic and chemical testing capabilities, discovery of genetic markers, and the development of new cannabis varieties via classical and marker assisted breeding. Alisha received a PhD in Biology from the University of Texas at Austin. She holds an assistant professor appointment at UCSF, and was the founding director of the Gladstone Institutes Bioinformatics Core Facility.

ATTENDANCE IS LIMITED. THE OPPORTUNITIES ARE NOT.

Image